Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 59,500
+100 (0.17%)
At close: Apr 30, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 488.13 billion as of April 30, 2026. Its market cap has increased by 43.18% in one year.
Market Cap
488.13B
Enterprise Value
458.85B
Revenue
16.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
59,500.00
Market Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 488.13B, an increase of 157.19%. That is a compound annual growth rate of 74.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 487.31B | -33.56% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mezoo | 498.52B |
| ASTERASYS Co.,Ltd | 431.59B |
| MEDIANA Co.,Ltd | 399.47B |
| L&K Biomed | 170.09B |
| SELVAS Healthcare | 111.61B |
| Remed | 95.50B |
| Neofect | 90.24B |
| Noul Co.,Ltd. | 84.84B |